Utilizing TH9 cells as a novel therapeutic strategy for malignancies

Yong Lu; Qing Yi

doi:10.4161/onci.23084

Utilizing T_H9 cells as a novel therapeutic strategy for malignancies

Yong Lu, Qing Yi

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

T_H9 cells join the ever-growing list of CD4⁺ T helper subsets and primarily mediate anti-parasite immune responses. We have recently demonstrated that tumor-specific T_H9 cells induce a CCL20-CCR6-dependent regulation of DCs while stimulating CD8⁺ T cell-mediated antitumor immunity. These findings offer a novel immunotherapeutic strategy against cancer.

Original language	English (US)
Article number	e23084
Journal	OncoImmunology
Volume	2
Issue number	3
DOIs	https://doi.org/10.4161/onci.23084
State	Published - Mar 2013

Keywords

Ccl20
DCs
Melanoma
TCLs
Th9 cell

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Oncology

Access to Document

10.4161/onci.23084

Cite this

@article{ac147600e5104222b5de6b43cb715cb2,

title = "Utilizing TH9 cells as a novel therapeutic strategy for malignancies",

abstract = "TH9 cells join the ever-growing list of CD4+ T helper subsets and primarily mediate anti-parasite immune responses. We have recently demonstrated that tumor-specific TH9 cells induce a CCL20-CCR6-dependent regulation of DCs while stimulating CD8+ T cell-mediated antitumor immunity. These findings offer a novel immunotherapeutic strategy against cancer.",

keywords = "Ccl20, DCs, Melanoma, TCLs, Th9 cell",

author = "Yong Lu and Qing Yi",

year = "2013",

month = mar,

doi = "10.4161/onci.23084",

language = "English (US)",

volume = "2",

journal = "OncoImmunology",

issn = "2162-4011",

publisher = "Landes Bioscience",

number = "3",

}

TY - JOUR

T1 - Utilizing TH9 cells as a novel therapeutic strategy for malignancies

AU - Lu, Yong

AU - Yi, Qing

PY - 2013/3

Y1 - 2013/3

N2 - TH9 cells join the ever-growing list of CD4+ T helper subsets and primarily mediate anti-parasite immune responses. We have recently demonstrated that tumor-specific TH9 cells induce a CCL20-CCR6-dependent regulation of DCs while stimulating CD8+ T cell-mediated antitumor immunity. These findings offer a novel immunotherapeutic strategy against cancer.

AB - TH9 cells join the ever-growing list of CD4+ T helper subsets and primarily mediate anti-parasite immune responses. We have recently demonstrated that tumor-specific TH9 cells induce a CCL20-CCR6-dependent regulation of DCs while stimulating CD8+ T cell-mediated antitumor immunity. These findings offer a novel immunotherapeutic strategy against cancer.

KW - Ccl20

KW - DCs

KW - Melanoma

KW - TCLs

KW - Th9 cell

UR - http://www.scopus.com/inward/record.url?scp=84886943372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886943372&partnerID=8YFLogxK

U2 - 10.4161/onci.23084

DO - 10.4161/onci.23084

M3 - Article

AN - SCOPUS:84886943372

SN - 2162-4011

VL - 2

JO - OncoImmunology

JF - OncoImmunology

IS - 3

M1 - e23084

ER -